Revenue segments as reported by the company.

Net revenue, before excise taxes

Excise taxes

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Sales and marketing

Research and development

General and administrative

Restructuring costs

Share-based payments

Depreciation and amortization

Impairment loss on goodwill and indefinite-lived intangible assets

Impairment loss on long-lived assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cronos Group

Cronos Group, Inc. engages in the production and distribution of cannabis. Its brands include PEACE NATURALS, COVE, Spinach, Lord Jones, and PEACE+. The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cronos Group, Inc. engages in the production and distribution of cannabis. I It operates through the Canada and Israel segments. The company was founded on August 21, 2012 and is headquartered in Toronto, Canada.

HEXO Corp

Are Canadian Cannabis Stocks On Your List For March? The post Top Marijuana Stocks To Watch On The Nasdaq Before March appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Top Marijuana Stocks To Watch On The Nasdaq Before March

Cronos (CRON) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Will Cronos Group (CRON) Report Negative Earnings Next Week? What You Should Know

Aurora Cannabis

CEA Industries

Canopy Growth

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

OrganiGram Holdings Inc.

SNDL Inc.

Trulieve Cannabis Corp.

Tilray Brands

Cannabis stocks are really cheap, but Alan Brochstein is worried about 3 things. Thoughts on Cresco/Columbia Care deal.

Looking For The Cheapest Cannabis Stocks (Transcript)

Canadian Pot Stocks To Watch Now The post Best Canadian Cannabis Stocks For Mid-February Watchlist appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Best Canadian Cannabis Stocks For Mid-February Watchlist

Village Farms International

Not a ton of great news out of the Canadian cannabis sector. Dispiriting earnings, layoffs and more reasons to be bearish.

Oh No, Canada

TORONTO, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2022 fourth quarter and full-year earnings conference call on Tuesday, February 28, 2023 at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks.

Cronos Group Inc. to Hold 2022 Fourth Quarter and Full-Year Earnings Conference Call on February 28, 2023

Netflix

One has a solid track record of success, while the other has consistently struggled to make its mark.

1 Growth Stock to Buy in 2023, and 1 to Avoid at all Costs

Spinach® gummies, known for incredible flavors and quality, are winning with adult consumers in the Canadian market

Spinach® Becomes the Number One Edible Brand in January¹

Marijuana Stocks To Watch In The Stock Market 2023 The post Top Marijuana Stocks In Todays Market appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Top Marijuana Stocks In Todays Market

Are These Canadian Pot Stocks A Buy In Q1 2023? The post Canadian Cannabis Stocks To Watch February 2023 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Canadian Cannabis Stocks To Watch February 2023

Bank of America

British American Tobacco

Anheuser-Busch InBev

Japan Tobacco Inc

Altria

Philip Morris

I've been getting reader requests lately for where to find yields better than the roughly 5% rate that cash is expected to pay in 2023. Well, here's one approach. Tobacco stocks are perennially cheap and feature hefty dividend yields.

Tobacco Trifecta: Go Where The Yields Are With Altria, Philip Morris, And British American Tobacco

The Best Canadian Marijuana Stock Investors Should Follow The post 2 Canadian Marijuana Stocks Investors Are Talking About appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

2 Canadian Marijuana Stocks Investors Are Talking About

I wrote a piece last October asking the simple question: whatever happened to the cannabis stock bubble? Biden's election was billed as a massive boost for the cannabis industry.

Why are cannabis stocks rising? Sector bounces following ugly 2022

Top Marijuana Stocks To Buy This Short Week? The post 2 Marijuana Stocks To Buy After MLK Day? appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

2 Marijuana Stocks To Buy After MLK Day?

Are These Best Canadian Marijuana Stocks To Buy In 2023? The post 3 Marijuana Stocks To Watch During The 2nd Week Of 2023 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

3 Marijuana Stocks To Watch During The 2nd Week Of 2023

Marijuana Stocks To Watch The First Week Of The New Year The post 2 Canadian Marijuana Stocks To Watch Today In 2023 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

2 Canadian Marijuana Stocks To Watch Today In 2023

Cannabis trends and investment activity in 2023 are likely to be influenced by Congress's failure to pass the SAFE Banking Act.

Cannabis Trends to Watch for in 2023

AFC Gamma

Beyond Meat

Cara Therapeutics

Amplify Seymour Cannabis ETF

Direxion Daily CSI China Internet Index Bull 2X Shares

Flora Growth Corp

GrowGeneration Corp

GW Pharmaceuticals

High Tide

Hydrofarm Holdings Group

Innovative Industrial Properties

Intercure Ltd

Amplify Alternative Harvest ETF

Cannabis REITs have been slammed this year amid concern over defaults from their cannabis cultivator tenants, which have been smoked by plunging wholesale cannabis prices and setbacks on federal legalization. The exclusion of the SAFE Banking Act from the omnibus federal spending package dimmed the once-high hopes that major federal marijuana legislation would be passed during the Biden Presidency.

Cannabis REITs: Smoked Out

Will Canadian Pot Stocks Recover In 2023? The post Are Canadian Marijuana Stocks On Your 2023 Watchlist? appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Are Canadian Marijuana Stocks On Your 2023 Watchlist?

The tobacco giant is abandoning warrants it held in the marijuana company and may dump some of its stock.

Is Altria About to Dump Cronos? Here's What It Could Mean for the Stock

There remains strong opposition to legalization of cannabis, particularly in more conservative areas of the United States and the rest of the world.

Cannabis Stocks Tumble On Third Failure Of SAFE Banking Act

Altria Group Inc, through its subsidiary Altria Summit LLC, has relinquished a warrant to buy more shares in Cronos Group Inc (NASDAQ:CRON, TSX:CRON) sending shares in the Canadian cannabis company, 5.9% lower. In March 2019, Altria acquired, through its subsidiaries, a 45% stake in Cronos plus the warrant which was exercisable until March 8, 2023, at a price of C$19.00 per share.

Altria Group relinquishes warrant which could have led to increased stake in Cronos Group

Altria Group Inc. MO, -0.83% said Monday it will continue to evaluate prospects of cannabis company Cronos Group Inc. CRON, +1.79% on whether it will acquire additional common shares of Cronos or dispose of them in the open market, in privately negotiated transactions with Cronos or third parties. Altria expects to claim a capital loss of $483 million on its U.S federal consolidated income tax return for 2022, related to its stake in Cronos Group.

Altria to claim $483 mln capital loss on cannabis company ownership stake

RICHMOND, Va.--( BUSINESS WIRE )--Altria Group, Inc (NYSE:MO) today announced that its wholly owned subsidiary, Altria Summit LLC, has notified Cronos Group Inc. (Cronos) of its irrevocable abandonment of (i) its warrant to purchase additional common shares of Cronos (the Warrant) and (ii) all rights that it may have held in the Warrant or any common shares underlying the Warrant for no consideration.

Altria Abandons Expiring Cronos Warrant; Maintains Initial Investment

TORONTO, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced that on December 16, 2022, Altria Group, Inc. (“Altria”) notified the Company that its wholly owned subsidiary, Altria Summit LLC, relinquished a warrant to subscribe for and purchase up to 84,243,223 common shares of the Company at a per share exercise price of C$19.00 (the “Warrant”) and all rights that it may have held in the Warrant or any common shares underlying the Warrant for no consideration. The voluntary relinquishment of the Warrant does not affect any rights of Altria under the Investor Rights Agreement between the Company and Altria, dated March 8, 2019. Altria continues to beneficially own 156,573,537 common shares of the Company and has four designees on the board of the Company, one of whom is independent.

Cronos Group Inc. Announces Receipt of Notice of Relinquishment of Warrant by Altria

News for Cronos Group Stock (CRON)